| scholarly article | Q13442814 |
| P50 | author | Kouichi Hosomi | Q92147598 |
| P2093 | author name string | Mitsutaka Takada | |
| Tomoya Higuchi | |||
| Mai Fujimoto | |||
| P2860 | cites work | Statins for the primary prevention of cardiovascular disease | Q24201513 |
| Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates | Q24647071 | ||
| The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393] | Q24793837 | ||
| Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
| Report of the Conference on Low Blood Cholesterol: Mortality Associations | Q28183069 | ||
| Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy | Q28732707 | ||
| Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial | Q29617817 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Data mining of the public version of the FDA Adverse Event Reporting System | Q30651235 | ||
| Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS). | Q33428656 | ||
| Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System | Q33542747 | ||
| Statin use and cancer risk: a comprehensive review | Q34021312 | ||
| Exposure to statins and risk of common cancers: a series of nested case-control studies | Q34028899 | ||
| Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients | Q46710487 | ||
| Statin use and the risk of bladder cancer: a population-based case-control study | Q47319683 | ||
| Statin use and the risk of 10 cancers. | Q51770029 | ||
| A Bayesian neural network method for adverse drug reaction signal generation. | Q52238255 | ||
| Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease | Q61070320 | ||
| Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma | Q61452554 | ||
| The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization | Q61964816 | ||
| The Risk of Cancer in Users of Statins | Q63865877 | ||
| Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin | Q67692210 | ||
| Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis | Q71666481 | ||
| Inverse association between serum total cholesterol and cancer mortality in Dutch civil servants | Q72796019 | ||
| Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis | Q77513498 | ||
| Pravastatin use and the five-year incidence of cancer in coronary heart disease patients: from the prevention of coronary sclerosis study | Q80209835 | ||
| Regulatory T lymphocytes: pivotal components of the host antitumor response | Q80495850 | ||
| The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells | Q81161461 | ||
| Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort | Q83462083 | ||
| Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer | Q87019274 | ||
| Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS. | Q34364050 | ||
| Carcinogenicity of lipid-lowering drugs | Q34368492 | ||
| Statins and cancer risk: a meta-analysis | Q34481478 | ||
| Statins and risk of cancer: a systematic review and metaanalysis | Q34585294 | ||
| HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis | Q34605246 | ||
| Tregs and rethinking cancer immunotherapy | Q34625147 | ||
| A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. | Q34629802 | ||
| Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials | Q34657456 | ||
| CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. | Q34718815 | ||
| Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas | Q34929092 | ||
| Statin use and breast cancer: prospective results from the Women's Health Initiative. | Q36480676 | ||
| Statin use and cancer risk in the General Practice Research Database | Q36694570 | ||
| Immunosenescence of ageing | Q36698262 | ||
| Novel statistical tools for monitoring the safety of marketed drugs | Q36835511 | ||
| Statin use in primary inflammatory breast cancer: a cohort study. | Q37040602 | ||
| Statins and cancer: A systematic review and meta-analysis | Q37245345 | ||
| Lower serum levels of total cholesterol are associated with higher urinary levels of 8-hydroxydeoxyguanosine | Q37363819 | ||
| Quantitative signal detection using spontaneous ADR reporting | Q37439662 | ||
| Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. | Q37511294 | ||
| Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor. | Q38519321 | ||
| Endogenous DNA damage as related to cancer and aging | Q38682994 | ||
| Serum cholesterol and risk of cancer in a cohort of 39,000 men and women | Q39648674 | ||
| Atorvastatin: a potential chemopreventive agent in bladder cancer | Q40339220 | ||
| Simvastatin induces death of multiple myeloma cell lines | Q40490105 | ||
| Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database | Q42281184 | ||
| Incidence of cancer and statin usage--record linkage study | Q43279302 | ||
| Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin | Q43604509 | ||
| Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial | Q43607472 | ||
| Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells | Q43714923 | ||
| 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis | Q43879339 | ||
| Statins have biphasic effects on angiogenesis | Q43882419 | ||
| Serum cholesterol and the incidence of cancer in a large cohort | Q43954571 | ||
| 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. | Q44079675 | ||
| Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). | Q45036700 | ||
| Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study | Q45063452 | ||
| The association between statins and cancer incidence in a veterans population | Q45332064 | ||
| Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis | Q46072124 | ||
| Statin treatment does not cause cancer | Q46356424 | ||
| Statins, low-density lipoprotein cholesterol, and risk of cancer | Q46356429 | ||
| Statins and cancer risk | Q46675467 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | database | Q8513 |
| data mining | Q172491 | ||
| P304 | page(s) | 223-233 | |
| P577 | publication date | 2015-01-22 | |
| P1433 | published in | International Journal of Medical Sciences | Q10927439 |
| P1476 | title | Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database | |
| P478 | volume | 12 |
| Q40394925 | A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department |
| Q37227402 | Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan |
| Q57292050 | An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs |
| Q35581401 | Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors |
| Q31144205 | Association between Benzodiazepine Use and Dementia: Data Mining of Different Medical Databases |
| Q90344371 | Association between oral anticoagulants and osteoporosis: Real-world data mining using a multi-methodological approach |
| Q60046340 | Effect estimate comparison between the prescription sequence symmetry analysis (PSSA) and parallel group study designs: A systematic review |
| Q33746359 | HSP105 prevents depression-like behavior by increasing hippocampal brain-derived neurotrophic factor levels in mice |
| Q97595716 | Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System |
| Q90413321 | Re-evaluating statin activity in cancer |
| Q38683173 | Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies |
| Q46238760 | Statin consumption as a risk factor for developing colorectal cancer: a retrospective case study. |
| Q37700224 | Statin use and all-cause and cancer mortality: BioBank Japan cohort |
| Q37690366 | Variability in statin-induced changes in gene expression profiles of pancreatic cancer. |
Search more.